Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Trop. Dis.

Sec. Neglected Tropical Diseases

Volume 6 - 2025 | doi: 10.3389/fitd.2025.1555191

This article is part of the Research TopicThe Role of Diagnostics in Eliminating Schistosomiasis as a Public Health Problem: Trend and NeedView all 5 articles

Schistosomiasis mapping in Senegal: from baseline to present

Provisionally accepted
Ndeye Mbacke KaneNdeye Mbacke Kane1Khadime SyllaKhadime Sylla2Ngayo SyNgayo Sy3Boubacar DiopBoubacar Diop4Rose MonteilRose Monteil5Malang ManéMalang Mané5Daouda GueyeDaouda Gueye1Bassirou GueyeBassirou Gueye1Momadou Laye SambMomadou Laye Samb1Babacar Banda DIALLOBabacar Banda DIALLO5Madeline WooMadeline Woo6Julie RitterJulie Ritter6Darin EvansDarin Evans7Anna PhillipsAnna Phillips6*
  • 1Programme National de lutte contre les MTN, Ministère de la Santé et de l'Action Sociale, Dakar, Senegal
  • 2Service département parasitologie - Universite Cheikh Anta Diop, Dakar, Senegal
  • 3Service de Lutte Antiparasitaire de Thiès, Thies, Senegal
  • 4Ministère de la Santé Publique et Action Sociale, Dakar, Dakar, Senegal
  • 5Family Health International 360 (Senegal), Dakar, Senegal
  • 6Family Health International 360, Washington DC, United States
  • 7United States Agency for International Development, Washington D.C., District of Columbia, United States

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Schistosomiasis has been a major public health concern in Senegal for almost 40 years.Dispensing praziquantel through mMass drug administration (MDA) is the primary control strategy for treating schistosomiasis, however, there is a global limited availability of praziquantel, and therefore not all at-risk groups can be adequately treated. For settings in Senegal where there are numerous permanent bodies of water and persistent water contact, reducing prevalence and maintaining progress is challenging as reinfection occurs rapidly and can quickly return to pre-treatment levels. In this paper we conducted the first comprehensive examination of the progress to reducecompare schistosomiasis prevalence since the implementation offollowing nearly 10 rounds of MDA beginning nearly 20 years ago . We also

Keywords: Schistosomiasis, Schistosoma mansoni, Schistosoma haematobium, Mass drug administration, sub-district level implementation, Senegal, neglected tropical disease Font: Italic Formatted: Font: Italic Formatted: Font: (Default) Times New Roman, 12 pt

Received: 10 Jan 2025; Accepted: 26 May 2025.

Copyright: © 2025 Kane, Sylla, Sy, Diop, Monteil, Mané, Gueye, Gueye, Samb, DIALLO, Woo, Ritter, Evans and Phillips. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Anna Phillips, Family Health International 360, Washington DC, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material